Get the Stockscreener App
36.10
6.65%
2.25
Pre-market:
35.39
-0.71
-1.97%
Harrow Inc stock is traded at $36.10, with a volume of 242.30K.
It is up +6.65% in the last 24 hours and up +5.49% over the past month.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.
See More
Previous Close:
$33.85
Open:
$34.51
24h Volume:
242.30K
Relative Volume:
0.52
Market Cap:
$1.29B
Revenue:
$154.15M
Net Income/Loss:
$-33.58M
P/E Ratio:
-37.60
EPS:
-0.96
Net Cash Flow:
$-20.74M
1W Performance:
+7.66%
1M Performance:
+5.49%
6M Performance:
+44.34%
1Y Performance:
+281.20%
1-Day Range:
$33.94
$36.10
1-Week Range:
$33.04
$36.13
52-Week Range:
$9.13
$59.23
Harrow Inc Stock (HROW) Company Profile
Name
Harrow Inc
Sector
Phone
615.733.4731
Address
102 WOODMONT BLVD, NASHVILLE, CA
Compare HROW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
36.10 | 1.29B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-04-24 | Reiterated | B. Riley Securities | Buy |
| Apr-11-24 | Initiated | Craig Hallum | Buy |
| Sep-08-22 | Resumed | B. Riley Securities | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Sep-24-21 | Initiated | Aegis Capital | Buy |
| Jul-02-21 | Initiated | Ladenburg Thalmann | Buy |
View All
Harrow Inc Stock (HROW) Latest News
Assenagon Asset Management S.A. Sells 79,071 Shares of Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Brookstone Capital Management Invests $275,000 in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow (NASDAQ:HROW) Stock Price Down 4.1%Should You Sell? - MarketBeat
JPMorgan Chase & Co. Purchases 194,480 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow, Inc. (NASDAQ:HROW) Shares Acquired by JPMorgan Chase & Co. - MarketBeat
Harrow appoints new Chief Scientific Officer - Investing.com
Harrow announces Amir Shojaei, PharmD, PhD joins as CSO - TipRanks
Harrow Appoints Amir H. Shojaei as Chief Scientific Officer - Business Wire
Principal Financial Group Inc. Takes Position in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow Inc (NASDAQ: HROW): On Track To A Higher Share Price - Stocks Register
Those Derisked Baby Bonds Of Harrow, Inc (NASDAQ:HROWM) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Up 7.7%Should You Buy? - MarketBeat
Franklin Resources Inc. Reduces Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (HROW) is on the Move, Here's Why the Trend Could be Sustainable - MSN
Harrow Inc (HROW) Stock Price Down 4.85% on Dec 27 - GuruFocus.com
Oversold Conditions For Harrow (HROW) - Nasdaq
Geode Capital Management LLC Buys 3,960 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Barclays PLC Buys 39,506 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
Barclays PLC Boosts Stake in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow (NASDAQ:HROW) Stock Price Down 2.5%Here's What Happened - MarketBeat
HighTower Advisors LLC Sells 1,575 Shares of Harrow, Inc. (NASDAQ:HROW) - Defense World
State Street Corp Has $32.87 Million Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow’s Valuation Hinges On Lofty Growth Amid Persistent Financial Strains (NASDAQ:HROW) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires Shares of 32,678 Harrow, Inc. (NASDAQ:HROW) - MarketBeat
The Manufacturers Life Insurance Company Lowers Position in Harrow, Inc. (NASDAQ:HROW) - Defense World
Harrow Stock: The Triesence Relaunch (NASDAQ:HROW) - Seeking Alpha
Westside Investment Management Inc. Trims Stock Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Stifel Financial Corp Has $18.31 Million Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Charles Schwab Investment Management Inc. Boosts Stock Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Verition Fund Management LLC Acquires Shares of 21,147 Harrow, Inc. (NASDAQ:HROW) - MarketBeat
B. Riley Estimates Harrow's FY2024 Earnings (NASDAQ:HROW) - MarketBeat
B. Riley Predicts Harrow’s Q1 Earnings (NASDAQ:HROW) - Defense World
BNP Paribas Financial Markets Increases Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow is Now Oversold (HROW) - Nasdaq
Harrow Inc (HROW) Stock Price Down 5.03% on Dec 3 - GuruFocus.com
Quantbot Technologies LP Purchases New Holdings in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Braidwell LP Boosts Stock Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
HROW (Harrow) Profitability Rank : 4 (As of Sep. 2024) - GuruFocus.com
BBR Partners LLC Has $2.79 Million Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Penserra Capital Management LLC Purchases Shares of 44,180 Harrow, Inc. (NASDAQ:HROW) - MarketBeat
US Growth Stocks With High Insider Ownership To Watch - Simply Wall St
Connor Clark & Lunn Investment Management Ltd. Takes $5.86 Million Position in Harrow, Inc. (NASDAQ:HROW) - MarketBeat
Harrow subsidiary wins $34.9 million in trademark case By Investing.com - Investing.com South Africa
Harrow subsidiary wins $34.9 million in trademark case - Investing.com
Harrow’s ImprimisRx Subsidiary Receives $34.9 Million Unanimous Jury Verdict Award in ImprimisRx, LLC v. OSRX, Inc. - Business Wire
HROW (Harrow) Net Issuance of Preferred Stock : $0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Harrow Wins $34.9M Verdict in Major Trademark Infringement Case Against OSRX - StockTitan
HROW (Harrow) Capex-to-Operating-Cash-Flow : 0.20 (As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Cash Flow from Investing : $4.2 Mil (TTM As of Sep. 2024) - GuruFocus.com
HROW (Harrow) Change In Receivables : $-35.5 Mil (TTM As of Sep. 2024) - GuruFocus.com
Harrow Inc Stock (HROW) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):